Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Ciaoon Feb 11, 2024 9:05am
79 Views
Post# 35874333

RE:RE:RE:Hope for the Best, this is a viable path forward

RE:RE:RE:Hope for the Best, this is a viable path forward
tigerpro wrote: Is it legal that Gilles doesn't communicate with shareholders but frequently provides insider information to Prop?

Is it legal that Gilles pays Prop to spread wrong and misleading information to shareholders?

Can shareholders sue both of them in the future?




Hard to prove if material information is being selectively disclosed.

Easier to use the Board for neglecting fiduciary responsibility. This sham merger could be easier to prove, attempt to merge a low risk company with a high risk cash burning biotech but most of all not replacing Gilles given his record of poor performance over the decade. How can he sit collecting an annual 500K salary for pathetic results?! The board was made aware of this, documented in letters and without a response and no action to remove him, instead approving and it being part of a sham merger which entrenches him as a CEO. 
<< Previous
Bullboard Posts
Next >>